XNAS: DTIL
Precision Biosciences Inc Live Stock Price Today, Share Analysis and Chart
about
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for...
Read More
8.34
0.00
(0.00%)
5,291
XNAS Volume
XNAS 14 May, 2026 9:24 AM (EDT)
Board Meeting
The next board meeting for Precision Biosciences Inc is on 21 May 2026 for the purpose of Precision BioSciences Inc Annual General Meeting for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Precision Biosciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..